Skip to main content
Top
Published in: Journal of Cancer Education 1/2010

01-03-2010

Using the Values-Based History to Fine-Tune Advance Care Planning for Oncology Patients

Author: Eric E. Prommer

Published in: Journal of Cancer Education | Issue 1/2010

Login to get access

Abstract

There is no standardized approach to the discussion of advanced care planning. One approach to discussing advanced care planning involves the use of a values history. The values history focuses on questions related to overall health, personal relationships, and independence, as well as symptoms. The values history facilitates communication with the patient and allows the patient to express their view. This approach to patient communication is less threatening to patients and does not force the patient into thinking that they need the right answer. Values-based directives are less intrusive on a doctor's skill in making appropriate clinical decisions. They ask questions that require no technical skill and are easily done by other members of the health-care team. Values histories are useful in a wide range of situations where the doctor needs to understand the patient as a person. Compared to traditional, medicalized advance directives, values histories are less subject to the objections of not being clearly established at the time of their writing, or applicable in the circumstances that subsequently arise as in this case. They can help to validate preferences about treatment and also indicate appropriate courses of action that were not, or could not, be covered by traditional advance directives alone. This article illustrates the use of a values-based history in a patient with advanced head and neck cancer.
Literature
1.
go back to reference Martin DK, Thiel EC, Singer PA (1999) A new model of advance care planning: observations from people with HIV. Arch Intern Med 159(1):86–92CrossRefPubMed Martin DK, Thiel EC, Singer PA (1999) A new model of advance care planning: observations from people with HIV. Arch Intern Med 159(1):86–92CrossRefPubMed
2.
3.
go back to reference Landry FJ, Kroenke K, Lucas C, Reeder J (1997) Increasing the use of advance directives in medical outpatients. J Gen Intern Med 12(7):412–415CrossRefPubMed Landry FJ, Kroenke K, Lucas C, Reeder J (1997) Increasing the use of advance directives in medical outpatients. J Gen Intern Med 12(7):412–415CrossRefPubMed
4.
go back to reference A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274(20):1591–1598. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274(20):1591–1598.
5.
go back to reference Brett AS (1991) Limitations of listing specific medical interventions in advance directives. JAMA 266(6):825–828CrossRefPubMed Brett AS (1991) Limitations of listing specific medical interventions in advance directives. JAMA 266(6):825–828CrossRefPubMed
6.
go back to reference Doukas DJ, McCullough LB (1991) The values history. The evaluation of the patient's values and advance directives. J Fam Pract 32(2):145–153PubMed Doukas DJ, McCullough LB (1991) The values history. The evaluation of the patient's values and advance directives. J Fam Pract 32(2):145–153PubMed
7.
go back to reference Docker C (2000) Decisions to withdraw treatment. Values histories are more useful than advance directives. BMJ 320(7226):54CrossRefPubMed Docker C (2000) Decisions to withdraw treatment. Values histories are more useful than advance directives. BMJ 320(7226):54CrossRefPubMed
8.
go back to reference Cohen LM, Germain MJ, Poppel DM (2003) Practical considerations in dialysis withdrawal: “To have that option is a blessing”. JAMA 289(16):2113–2119CrossRefPubMed Cohen LM, Germain MJ, Poppel DM (2003) Practical considerations in dialysis withdrawal: “To have that option is a blessing”. JAMA 289(16):2113–2119CrossRefPubMed
9.
go back to reference Chris Docker to the BMA Living Wills Code of Practice Committee 11 January 1995. 2008. Ref Type: Generic Chris Docker to the BMA Living Wills Code of Practice Committee 11 January 1995. 2008. Ref Type: Generic
10.
go back to reference Morrison LJ, Morrison RS (2006) Palliative care and pain management. Med Clin North Am 90(5):983–1004CrossRefPubMed Morrison LJ, Morrison RS (2006) Palliative care and pain management. Med Clin North Am 90(5):983–1004CrossRefPubMed
Metadata
Title
Using the Values-Based History to Fine-Tune Advance Care Planning for Oncology Patients
Author
Eric E. Prommer
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2010
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-009-0014-0

Other articles of this Issue 1/2010

Journal of Cancer Education 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine